GGrantIndex
← Leaderboards

Dena Davidson

Indiana Univ-Purdue Univ At Indianapolis

$3,126,852
Attributed
$3,126,852
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $263.6K · FY200519
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$3,126,852 · 3
VA$0 · 1

By mechanism

R01$2,882,838 · 2
K01$244,014 · 1
I01$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Indiana Univ-Purdue Univ At Indianapolis

Same institution · by research overlap

Others in their field

Top investigators on “Alcoholism /Alcohol Abuse

Research focus

Alcoholism /Alcohol AbuseBehavioral /Social Science Research TagMotivationHuman SubjectClinical ResearchSubstance Abuse Related BehaviorAlcoholism /Alcohol Abuse ChemotherapyPharmaceutical PreparationsCombination TherapyCerebrospinal FluidAdrenal GlandsCombined Modality TherapyClinically RelevantClinical TrialsComplexDosageChronic Widespread PainClassification SchemeBiogenic AminesBrainCalcium ChannelCentral PainChronicActive Method

Grant awards (18)

RCT of Duloxetine & Pregabalin for the treatment of Gulf War Illness in Veterans$0
I01 · FY2019 · VA · contact PI
RCT of Duloxetine & Pregabalin for the treatment of Gulf War Illness in Veterans$0
I01 · FY2017 · VA · contact PI
RCT of Duloxetine & Pregabalin for the treatment of Gulf War Illness in Veterans$0
I01 · FY2016 · VA · contact PI
RCT of Duloxetine & Pregabalin for the treatment of Gulf War Illness in Veterans$0
I01 · FY2015 · VA · contact PI
RCT of Duloxetine & Pregabalin for the treatment of Gulf War Illness in Veterans$0
I01 · FY2014 · VA · contact PI
Craving & EtOH Intake in Alcoholics: a Test of 2 Models$214,052
R01 · FY2007 · AA · contact PI
Craving & EtOH Intake in Alcoholics: a Test of 2 Models$220,445
R01 · FY2006 · AA · contact PI
Craving &EtOH Intake in Alcoholics: a Test of 2 Models$225,750
R01 · FY2005 · AA
POST TREATMENT EFFECTS OF NALTREXONE$37,823
R01 · FY2005 · AA
POST TREATMENT EFFECTS OF NALTREXONE$246,835
R01 · FY2004 · AA
Craving &EtOH Intake in Alcoholics: a Test of 2 Models$225,750
R01 · FY2004 · AA
POST TREATMENT EFFECTS OF NALTREXONE$388,957
R01 · FY2003 · AA
Craving &EtOH Intake in Alcoholics: a Test of 2 Models$225,750
R01 · FY2003 · AA
POST TREATMENT EFFECTS OF NALTREXONE$385,599
R01 · FY2002 · AA
POST TREATMENT EFFECTS OF NALTREXONE$332,311
R01 · FY2001 · AA
METHODS FOR ASSESSING MEDICATIONS TO LOWER ETOH INTAKE$121,997
K01 · FY2001 · AA
POST TREATMENT EFFECTS OF NALTREXONE$379,566
R01 · FY2000 · AA
METHODS FOR ASSESSING MEDICATIONS TO LOWER ETOH INTAKE$122,017
K01 · FY2000 · AA